|
2022 Conference Publication Evaluating mono- and combination therapy of meropenem and amikacin against Pseudomonas aeruginosa bacteremia in the hollow-fiber infection modelAvent, Minyon, Mccarthy, Kate, Sime, Fekade, Naickera, Saiyuri, Heffernan, Aaron, Wallis, Steven, Paterson, David and Roberts, Jason A (2022). Evaluating mono- and combination therapy of meropenem and amikacin against Pseudomonas aeruginosa bacteremia in the hollow-fiber infection model. 32nd International Congress of Antimicrobial Chemotherapy (ICC), Perth, WA, Australia, 27-30 November 2022. Amsterdam, Netherlands: Elsevier . doi: 10.1016/s2213-7165(22)00314-9 |
|
2022 Conference Publication Optimising the management of vancomycin therapy utilisng co-designAvent, M., Franks, W., Daveson, K., Redmond, A. and Naicker, S. (2022). Optimising the management of vancomycin therapy utilisng co-design. 32nd International Congress of Antimicrobial Chemotherapy (ICC), Perth, WA Australia, 27-30 November 2022. Amsterdam, Netherlands: Elsevier. doi: 10.1016/s2213-7165(22)00332-0 |
|
2008 Conference Publication Drug use evaluation systems in Australasia – what’s new?Martin, J., Kubler, P., Avent, M., Patullo, C. and Dines, A.. (2008). Drug use evaluation systems in Australasia – what’s new?. AHMRC 2008, Brisbane, Australia, 16-21 November 2008. Australia: Australian Health and Medical Research Council. |
|
1995 Conference Publication Absorption and Tolerance of Oral Ampicillin in NeonatesAvent, ML, Gal, P, Ransom, JL, Diaz, PR, Carlos, RO, Smith, MS, Klarr, JM and Brown, YL (1995). Absorption and Tolerance of Oral Ampicillin in Neonates. |
